4-butyrolactone has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, X; Ji, S; Li, M; Li, X; Liu, X | 1 |
| Adlercreutz, H; Rissanen, TH; Salonen, JT; Vanharanta, M; Voutilainen, S | 1 |
2 other study(ies) available for 4-butyrolactone and Myocardial Ischemia
| Article | Year |
|---|---|
Screening of Bioactive Ingredients in Ligusticum Chuanxiong Hort for Protection against Myocardial Ischemia.
Topics: 4-Butyrolactone; Animals; Cardiotonic Agents; Chromatography, High Pressure Liquid; Coumaric Acids; Disease Models, Animal; Dogs; Ligusticum; Myocardial Infarction; Myocardial Ischemia; Plant Extracts; Reference Standards; Rhizome | 2016 |
Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study.
Topics: 4-Butyrolactone; Adult; Cause of Death; Finland; Follow-Up Studies; Humans; Lignans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Risk Assessment; Risk Factors | 2003 |